(Q35540189)

8 August 2017

1 reference

title

Update on epidemiological aspects of progressive supranuclear palsy (English)

1 reference

8 August 2017

1 reference

1 reference

12 March 2024

1

Irene Litvan

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.10562

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/mds.10562

12 March 2024

1 reference

12 March 2024

1 reference

8 August 2017

18 Suppl 6

1 reference

8 August 2017

S43-50

1 reference

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

8 August 2017

1 reference

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

21 January 2018

1 reference

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

21 January 2018

1 reference

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

Geographic patterns of parkinsonism-dementia complex on Guam. 1956 through 1985.

21 January 2018

1 reference

Patterns of acquiring parkinsonism-dementia complex on Guam. 1944 through 1985.

21 January 2018

1 reference

Parkinsonism caused by petroleum waste ingestion

21 January 2018

1 reference

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

21 January 2018

1 reference

Anti-inflammatory drugs and Alzheimer-type pathology in aging.

21 January 2018

1 reference

Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

A case-control study of Alzheimer's disease in China

21 January 2018

1 reference

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

Progressive supranuclear palsy: neuropathologic and clinical heterogeneity

21 January 2018

1 reference

Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy.

21 January 2018

1 reference

Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

21 January 2018

1 reference

Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study.

21 January 2018

1 reference

Head injury and the risk of AD in the MIRAGE study

21 January 2018

1 reference

Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study

21 January 2018

1 reference

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

21 January 2018

1 reference

Head injuries and cognitive decline among older adults: a population-based study

21 January 2018

1 reference

Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group.

21 January 2018

1 reference

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

21 January 2018

1 reference

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

21 January 2018

1 reference

Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy

21 January 2018

1 reference

21 January 2018

1 reference

Progressive supranuclear palsy and a multi-infarct state

21 January 2018

1 reference

Vascular progressive supranuclear palsy

21 January 2018

1 reference

Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms

21 January 2018

1 reference

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

21 January 2018

2

1 reference

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

12 March 2024

3

1 reference

Diagnosis and management of progressive supranuclear palsy

12 March 2024

4

1 reference

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

12 March 2024

5

1 reference

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

12 March 2024

6

1 reference

Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

12 March 2024

7

1 reference

Tau protein pathology in neurodegenerative diseases.

12 March 2024

8

1 reference

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms

12 March 2024

9

1 reference

Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.

12 March 2024

10

1 reference

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

12 March 2024

11

1 reference

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

12 March 2024

12

1 reference

12 March 2024

13

54

Boeve

2003

1 reference

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

12 March 2024

16

1 reference

Proceedings of the Australian Association of Neurologists

12 March 2024

17

10

35

Mastaglia

1973

1 reference

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

12 March 2024

18

1 reference

Prevalence and natural history of progressive supranuclear palsy

12 March 2024

19

1 reference

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

12 March 2024

20

1 reference

Progressive supranuclear palsy: a survey of the disease course.

12 March 2024

21

1 reference

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

12 March 2024

22

1 reference

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study

12 March 2024

23

1 reference

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

12 March 2024

25

1 reference

Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP

12 March 2024

26

1 reference

Progressive supranuclear palsy in the molecular age

12 March 2024

27

1 reference

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

12 March 2024

28

1 reference

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

12 March 2024

29

1 reference

Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

12 March 2024

30

1 reference

Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

12 March 2024

31

1 reference

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements

12 March 2024

33

1 reference

A distinct familial presenile dementia with a novel missense mutation in the tau gene

12 March 2024

34

1 reference

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

12 March 2024

35

1 reference

Tau is a candidate gene for chromosome 17 frontotemporal dementia

12 March 2024

36

1 reference

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

12 March 2024

37

1 reference

Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

12 March 2024

38

1 reference

Phenotypic variation in hereditary frontotemporal dementia with tau mutations.

12 March 2024

39

1 reference

Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group

12 March 2024

41

1 reference

Drug Metabolism and Disposition

12 March 2024

43

19

257

Kikuchi

1991

1 reference

A novel and neurotoxic tetrahydroisoquinoline derivative in vivo: formation of 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, a condensation product of amphetamines, in brains of rats under chronic ethanol treatment.

12 March 2024

44

1 reference

Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry

12 March 2024

45

1 reference

Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.

12 March 2024

46

1 reference

Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry

12 March 2024

47

1 reference

1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.

12 March 2024

48

1 reference

Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.

12 March 2024

49

1 reference

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

12 March 2024

50

1 reference

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate.

12 March 2024

51

1 reference

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

12 March 2024

52

1 reference

Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes

12 March 2024

53

1 reference

Pesticide study aids Parkinson research.

12 March 2024

55

1 reference

Differential cytotoxicities of N-methyl-beta-carbolinium analogues of MPP+ in PC12 cells: insights into potential neurotoxicants in Parkinson's disease

12 March 2024

56

1 reference

Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.

12 March 2024

58

1 reference

Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients

12 March 2024

59

1 reference

Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter.

12 March 2024

60

1 reference

Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).

12 March 2024

61

1 reference

Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: Compounds related to Parkinson's disease

12 March 2024

62

1 reference

Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods

12 March 2024

63

1 reference

Four cases of progressive supranuclear palsy in patients exposed to organic solvents

12 March 2024

68

1 reference

n-hexane induces parkinsonism in rodents.

12 March 2024

70

1 reference

Parkinsonism due to n-hexane exposure

12 March 2024

71

1 reference

Environmental— occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation

12 March 2024

72

1 reference

Risk factors for progressive supranuclear palsy

12 March 2024

73

1 reference

Follow-up study of risk factors in progressive supranuclear palsy

12 March 2024

74

1 reference

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

12 March 2024

76

1 reference

Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease

12 March 2024

77

1 reference

Transforming growth factor-beta: neuronal and glial expression in CNS degenerative diseases

12 March 2024

81

1 reference

TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy

12 March 2024

83

1 reference

Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy.

12 March 2024

84

1 reference

Presymptomatic hypertension in progressive supranuclear palsy. Study Group on Atypical Parkinsonisms

12 March 2024

92

1 reference

Neuronal cytoskeletal changes are an early consequence of repetitive head injury

12 March 2024

94

1 reference

Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease: a report on three patients

12 March 2024

95

1 reference

Trauma and movement disorders

12 March 2024

96

1 reference

Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

12 March 2024

97

1 reference

Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders

12 March 2024

101

1 reference

Association of coffee and caffeine intake with the risk of Parkinson disease

12 March 2024

110

1 reference

A retrospective study of smoking in Parkinson's disease.

12 March 2024

111

1 reference

12 March 2024

Identifiers

DOI

10.1002/MDS.10562

1 reference

release_3i27t5tctvclfkv5xthbw253oe

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3i27t5tctvclfkv5xthbw253oe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference